Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
#:"(allfields_unstemmed:2019-nCov OR allfields:2019nCov OR allfields_unstemmed:2019nCov OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 NOT format:Book NOT collection_details:ZDB-2-SEB)"
(allfields_unstemmed:2019-nCov OR allfields:2019nCov OR allfields_unstemmed:2019nCov OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 NOT format:Book NOT collection_details:ZDB-2-SEB)
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22KE+CHANGWEN%22&type=Person&filter%5B%5D=%28allfields_unstemmed%3A2019-nCov+OR+allfields%3A2019nCov+OR+allfields_unstemmed%3A2019nCov+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19++NOT+format%3ABook+NOT+collection_details%3AZDB-2-SEB%29
/vufind/Search/Results?lookfor=%22KE+CHANGWEN%22&type=Person&filter%5B%5D=%28allfields_unstemmed%3A2019-nCov+OR+allfields%3A2019nCov+OR+allfields_unstemmed%3A2019nCov+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19++NOT+format%3ABook+NOT+collection_details%3AZDB-2-SEB%29
Search /vufind/Search2/Results?lookfor=%22KE+CHANGWEN%22&type=Person&filter%5B%5D=%28allfields_unstemmed%3A2019-nCov+OR+allfields%3A2019nCov+OR+allfields_unstemmed%3A2019nCov+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19++NOT+format%3ABook+NOT+collection_details%3AZDB-2-SEB%29
PubPharm (56)
1
The receptor binding domain of SARS-CoV-2 Omicron subvariants targets Siglec-9 to decrease its immunogenicity by preventing macrophage phagocytosis
enthalten in:
Nature immunology
| 2024
von
He, X.
|
Zhang, X.
|
Wu, B.
| +35
Wird geladen...
2
Polymorphisms of IFN signaling genes and FOXP4 influence the severity of COVID-19
enthalten in:
BMC infectious diseases
| 2024
von
Zhang, F.
|
Zhou, P.
|
Wang, L.
| +5
Wird geladen...
3
Potent Antibody Response Elicited by a Third Booster Dose of Inactivated COVID-19 Vaccine in Healthy Subjects
enthalten in:
Viral immunology
| 2023
von
Ji, R.
|
Zhang, J.
|
Liang, D.
| +9
Wird geladen...
4
SARS-CoV-2 ORF3a sensitizes cells to ferroptosis via Keap1-NRF2 axis
enthalten in:
Redox biology
| 2023
von
Liu, L.
|
Du, J.
|
Yang, S.
| +12
Wird geladen...
5
Emergence of epidemic variants of SARS-CoV-2 by acquiring combinations of new highly mutable nucleotides in its genome
enthalten in:
The Journal of infection
| 2023
von
Wang, H.
|
Liu, Y.
|
Li, P.
| +26
CommentOn: J Infect. 2023 May;86(5):513-515. - PMID 36764392
Wird geladen...
6
SARS-CoV-2 breakthrough infections induce somatically hypermutated broadly neutralizing antibodies against heterologous variants
enthalten in:
ResearchSquare.com
| 2023
von
Xiong, X.
|
Yu, H.
|
Wang, Y.
| +36
Wird geladen...
7
Somatically hypermutated antibodies isolated from SARS-CoV-2 Delta infected patients cross-neutralize heterologous variants
enthalten in:
Nature communications
| 2023
von
Yu, H.
|
Liu, B.
|
Zhang, Y.
| +36
Wird geladen...
8
Design, synthesis and immunological evaluation of monophosphoryl lipid A derivatives as adjuvants for a RBD-hFc based SARS-CoV-2 vaccine
enthalten in:
RSC medicinal chemistry
| 2023
von
Su, S.
|
Chen, L.
|
Yang, M.
| +7
Wird geladen...
9
The instantly blocking-based fluorescent immunochromatographic assay for the detection of SARS-CoV-2 neutralizing antibody
enthalten in:
Frontiers in cellular and infection microbiology
| 2023
von
Li, Y.
|
He, J.
|
Zhang, Y.
| +9
Wird geladen...
10
A tandem-repeat dimeric RBD protein-based COVID-19 vaccine ZF2001 protects mice and nonhuman primates
enthalten in:
bioRxiv.org
| 2022
von
An, Y.
|
Li, S.
|
Jin, X.
| +25
Wird geladen...
1
2
3
4
5
6
Nächster »
[6]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Filter aufheben
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Medienart
56
Aufsätze
55
E-Artikel
55
E-Ressourcen
1
Gedruckte Aufsätze
Zeitschriftentitel
9
bioRxiv.org
3
Nature communications
3
Virology journal
2
Cell
2
Cellular & molecular immunology
2
Emerging microbes & infections
2
Europäisches Patentamt
2
Frontiers in cellular and infection microbiology
2
ResearchSquare.com
2
Signal transduction and targeted therapy
1
ACS nano
1
Advanced Science
1
Advanced science (Weinheim, Baden-Wurttemberg, ...
1
BMC infectious diseases
1
Biosafety and health
1
Biosensors & bioelectronics
1
Cell reports
1
Chemical communications (Cambridge, England)
1
China CDC weekly
1
Clinical microbiology and infection : the offic...
Alle anzeigen ...
weniger ...
Thema
36
Journal Article
20
Research Support, Non-U.S. Gov't
17
Antibodies, Viral
17
SARS-CoV-2
16
Antibodies, Neutralizing
13
Spike Glycoprotein, Coronavirus
10
COVID-19 Vaccines
9
COVID-19
9
spike protein, SARS-CoV-2
4
Angiotensin-Converting Enzyme 2
4
EC 3.4.17.23
4
Immunoglobulin G
4
Neutralizing antibodies
4
SARS-CoV-2 variants
4
neutralizing antibody
3
Ace2 protein, mouse
3
Immunoglobulin M
3
RNA, Viral
3
Vaccine
3
Viral Vaccines
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
55
2020-
1
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
54
Englisch
Haven't found what you're looking for?
Wird geladen...